Open App

Sign in (current)
Privacy Policy (current)
Contact us (current)

Are you sure you want to log out?
You can always login again from the home screen

Yes

Thank You

Thank you for your feedback

Forgot password?

Forgot password?

This Web-portal is created as educational service for healthcare professionals practicing in Middle East only.
This Web-portal is fully funded and supported by Gilead Sciences.
This Web-portal is not meant to give any medical or clinical advice, the information mentioned here might be outdated or not inline with local prescribing information for any mentioned product, Gilead sciences is not recommending the use of any product in any manner other than as described in local prescribing information.
For any technical questions relating to this Web-Portal, please contact
GMED.support@gilead.com
For any questions related to Gilead products or therapeutic areas, please contact:
askgileadME@gilead.com
Reporting suspected adverse reactions of the medicinal product is important.
It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals and patients are asked to report any suspected adverse reactions via the national reporting schemes as applicable Adverse reactions may also be reported directly to the manufacturer of the suspected product. Adverse reactions related to Gilead products may be reported directly to Gilead via: Drugsafety.dubai@gilead.com.
Safety information will be collected and sent to Global Patient Safety department department to meet our legal obligations.

Download our GMED Mobile App

© 2020 Gilead Sciences, Inc. All rights reserved.

ME-GIL-2020-10-0002; Prepared: Dec 2020